Compare BWEN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWEN | RFL |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Real Estate |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 61.1M |
| IPO Year | 2009 | 2017 |
| Metric | BWEN | RFL |
|---|---|---|
| Price | $2.41 | $1.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 247.6K | 57.5K |
| Earning Date | 05-09-2026 | 03-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.28 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $146,785,000.00 | $917,000.00 |
| Revenue This Year | $11.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.93 | ★ N/A |
| Revenue Growth | N/A | ★ 43.96 |
| 52 Week Low | $1.41 | $1.12 |
| 52 Week High | $4.15 | $3.19 |
| Indicator | BWEN | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 52.38 |
| Support Level | $2.29 | $1.17 |
| Resistance Level | $2.49 | $1.28 |
| Average True Range (ATR) | 0.20 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 25.00 | 61.54 |
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.